Researchers: Generic AIDS pill is as good as more expensive ones

07/1/2004 | Wall Street Journal, The

An international team of researchers said a clinical study shows a three-in-one Indian pill, Cipla's Triomune, did as well as the more expensive branded drugs, leading them to advocate its use in developing countries. The study, conducted in Cameroon, may help answer concerns about the effectiveness of generic fixed-dose combinations. Those concerns have led some international AIDS donors to reject funding for the generic pills.

View Full Article in:

Wall Street Journal, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Financial Officer
B. E. Smith
Miramar, FL
Director of ASO Department
Bluegrass Family Health
Lexington-or could be in Nashville, TN, KY
Claims Director
PacificSource
Springfield, OR
Mgr NGS Provider Enrollment (I)
National Government Services - WellPoint
Harrisburg, PA
NGS Provider Enrollment Rep
National Government Services - WellPoint
Harrisburg, PA